Cargando…

Precision and recall oncology: combining multiple gene mutations for improved identification of drug-sensitive tumours

Cancer drug therapies are only effective in a small proportion of patients. To make things worse, our ability to identify these responsive patients before administering a treatment is generally very limited. The recent arrival of large-scale pharmacogenomic data sets, which measure the sensitivity o...

Descripción completa

Detalles Bibliográficos
Autores principales: Naulaerts, Stefan, Dang, Cuong C., Ballester, Pedro J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722542/
https://www.ncbi.nlm.nih.gov/pubmed/29228590
http://dx.doi.org/10.18632/oncotarget.20923